10 mm, lymph-vascular space involvement, tumor diameter > 17.5 mm, and parametrial involvement. Postoperative treatment was significantly more frequent in patients with "abundant" vascularization (OR: 20.8, 95% CIs: 2 to 211). The presence of scanty-moderate vascularization with a PI < 0.82 or abundant vascularization with either PI > 0.82 or PI < 0.82 was associated with high-risk group in 94.4% of the cases (OR: 21.2, 95% CI: 1.9 to 236.0) Conclusion The results are consistent with a relationship between tumor angiogenesis and prognostic factors for recurrence in early cervical cancer. "Abundant" vascularization and PI < 0.82 may be related to postoperative treatment due to risk factors."/>
n | % | |
---|---|---|
FIGO Stage | ||
Ia2 | 1 | 3.7 |
Ib1 | 25 | 92.6 |
IIa | 1 | 3.7 |
Tumor size (cm)* | 2.2 | (1–3.9) |
Histology | ||
SCC | 18 | 66.7 |
Non-SCC | 9 | 33.3 |
Grade 1 | 11 | 40.7 |
Grade 2 | 13 | 48.1 |
Grade 3 | 3 | 11.1 |
Surgery | ||
RH-II | 22 | 81.5 |
RH-III | 5 | 18.5 |
PLND** | 14 | (4–37) |
+ | 5 | 18.5 |
-- | 22 | 81.4 |
DSI (mm) < 10 | 8 | 29.6 |
DSI > 10 mm | 19 | 70.4 |
LVSI+ | 9 | 33.3 |
LVSI- | 17 | 62.9 |
LVSI Unknown | 1 | 3.7 |
Postop. Treat. | ||
EPRT + Brachitherapy | 11 | 40.7 |
Chemoradiation | 7 | 25.9 |
No | 9 | 33.3 |